» Articles » PMID: 35765977

Acute Acalculous Cholecystitis As an Early Manifestation of COVID-19: Case Report and Literature Review

Overview
Journal Acta Biomed
Specialty General Medicine
Date 2022 Jun 29
PMID 35765977
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The novel coronavirus disease 2019 (COVID-19) has rapidly spread worldwide since the outbreak in Wuhan, China, in 2019, becoming a major threat to public health. The most common symptoms are fever, dry cough, shortness of breath, but subjects with COVID-19 may also manifest gastrointestinal symptoms, and in a few cases an involvement of the gallbladder has been observed. Case report: Here we present a case of 50-year-old male with SARS-CoV-2 infection who had abdominal pain, vomiting and diarrhea without respiratory symptoms and was finally diagnosed as acute acalculous cholecystitis (AAC). Laparoscopic cholecystectomy was performed and found a gangrenous gallbladder; the real-time reverse transcription polymerase chain reaction SARS-CoV-2 nucleic acid assay of the bile was negative. We also made a review of the literature and try to understand the hypothetic role of SARS-CoV-2 in the pathogenesis of AAC. Conclusions: We highlighted that it is noteworthy to look at gastrointestinal symptoms in patients with SARS-CoV-2 infection and take into account AAC as a possible complication of COVID-19. Although more evidence is needed to better elucidate the role of the pathogenic mechanisms of the SARS-CoV-2 in AAC, it is conceivable that the hepatobiliary system could be a potential target of SARS-CoV-2.

Citing Articles

Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review.

Thomaidou E, Karlafti E, Didagelos M, Megari K, Argiriadou E, Akinosoglou K Viruses. 2024; 16(3).

PMID: 38543820 PMC: 10976146. DOI: 10.3390/v16030455.


Acute acalculous cholecystitis as a rare gastroenterological association of COVID-19: a case series and systematic review.

Awan J, Akhtar Z, Inayat F, Farooq A, Goraya M, Ishtiaq R J Clin Transl Res. 2023; 9(2):133-143.

PMID: 37179790 PMC: 10171317.


The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?.

De Simone B, Abu-Zidan F, Chouillard E, Di Saverio S, Sartelli M, Podda M World J Emerg Surg. 2022; 17(1):61.

PMID: 36527038 PMC: 9755784. DOI: 10.1186/s13017-022-00466-4.

References
1.
Balmadrid B . Recent advances in management of acalculous cholecystitis. F1000Res. 2018; 7. PMC: 6194724. DOI: 10.12688/f1000research.14886.1. View

2.
Huffman J, Schenker S . Acute acalculous cholecystitis: a review. Clin Gastroenterol Hepatol. 2009; 8(1):15-22. DOI: 10.1016/j.cgh.2009.08.034. View

3.
Alhassan S, Iqbal P, Fikrey L, Mohamed Ibrahim M, Qamar M, Chaponda M . Post COVID 19 acute acalculous cholecystitis raising the possibility of underlying dysregulated immune response, a case report. Ann Med Surg (Lond). 2020; 60:434-437. PMC: 7664478. DOI: 10.1016/j.amsu.2020.11.031. View

4.
Ying M, Lu B, Pan J, Lu G, Zhou S, Wang D . COVID-19 with acute cholecystitis: a case report. BMC Infect Dis. 2020; 20(1):437. PMC: 7306929. DOI: 10.1186/s12879-020-05164-7. View

5.
Balaphas A, Gkoufa K, Meyer J, Peloso A, Bornand A, McKee T . COVID-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall. J Hepatol. 2020; 73(6):1566-1568. PMC: 7467103. DOI: 10.1016/j.jhep.2020.08.020. View